PrEP 2.0: TDF/FTC and Beyond - State of the Science and the Product and Delivery System Pipeline

PrEP 2.0: TDF/FTC and Beyond – State of the Science and the Product and Delivery System Pipeline is organized by International Antiviral Society (IAS-USA) and will be held on Jun 25, 2019. 

Who Should Attend
This advanced webinar is designed for clinical decision makers who are actively involved in HIV care and research.
This activity is also relevant for registered nurses, PharmDs, and other health professionals.

Assessment of Needs:
The IAS–USA offers this free state-of-the-art activity as part of a nationwide continuing medical education (CME) effort for physicians on the evolving challenges of managing HIV disease. We will review the current state of the evidence for daily and “on-demand” or “2-1-1” TDF-based PrEP, with a particular emphasis on differences best practices based on route of HIV exposure. In follow-up, we will also consider the near- and far-term pipelines for novel agents promising for use as PrEP, as well as novel delivery systems and timelines for anticipated evidence being available. Finally, we will look at some challenges of making new/incident HIV diagnoses in the context of TDF-based PrEP. The webinar will present Insights and approaches to troubleshooting difficult cases, and we will close with some forward-looking caveats about diagnosing new/incident infections in the context of the anticipated PrEP pipeline.

Accreditation:
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits
Educational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This program is approved for 1.25 hours of continuing nursing education.

Educational Review Systems has also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.

This program is approved for 1.25 hours of pharmacotherapy credit.

Pharmacy Credits
Accreditation Council for Pharmacy Education logo Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 1.25 hours (0.125 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.

Learning Objectives
On completion of this webinar, learners will be able to:
• Describe the current evidence for the efficacy of TDF-based PrEP (daily and “on-demand”)
• Describe the range of PrEP agents currently in development
• Describe the challenges with HIV infection diagnosis in the PrEP context